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Abstract

Cancer is one of the most deadly diseases that the world has been fighting against over
decades. An enormous number of research has been conducted, via a wide scale of approaches, raging from genetic analysis to mathematical modeling. Survival analysis is a
well-performed methodology frequently used to estimate the survival probability of a patient.
Although there has been a large number of methods for survival analysis, efficient exploration
of a high-dimensional feature space has been challenging due to its computational cost and
complexity. This thesis adapts the component-wise gradient boosting algorithms for cancer
survival analysis, and also proposes a new gradient boosting algorithm based on optimizing
the Brier’s score. The new method is illustrated with the analysis of the microarray data of
diffuse large B-cell lymphoma (DLBCL). The new gradient boosting approach not only has
identified similar important biomarkers as previous statistical studies on the same data set,
but also offers more insights and gained understanding on medical aspects. In addition, the
performance of the new method is demonstrated through a simulation study and compared
with a variety of statistical and machine learning methods.

1

1.1

Introduction

Cancer

Cancer is a collection of related diseases, which the body’s cells start to divide without
stopping and inflate the surrounding tissues. Normally, human cells grow and duplicate in
demand of body need. New cells are continuously reproduced to replace dead or damaged
cells. In appearance of cancer, however, cells growth abnormally, old and damaged cells
are not eliminated as usual and new cells are duplicated abundantly. In many cases, these
cells can keep dividing without limitation and may form tumors. Malignant tumors, which
are dangerous and deadly, invade the nearby tissues and compete with normal cells for
nutrient. Additionally, this type of cancerous tumors can break off and metastasize to a
new distant site via the blood or lymph system. The metastasis may form new tumors
far from the original tumor (primary site of cancer). On the other hand, benign tumors
do not invade the neighbor environment and can be removed. Hardly ever benign tumors
grow back, while the malignant tumors sometimes do [2]. Based on the annual report of
American Cancer Society, 1,762,450 new cancer cases were recorded in 2019, resulting in
606,880 deaths [2]. The most common site with cancer development is the digestive system
with 328,030 new cases, discovered in the same year. The trend in age-adjusted cancer
death rates (both sexes) from 1930 to 2016 has witnessed a significant increase in lung and
bronchus sites and a gradual decrease in stomach site. The survival rate within 5 years
for all cancers has grown remarkably since early 1960s, and is nearly doubled from 39% to
70% among whites and tripled from 27% to 63% among blacks. This thesis develops a new

machine learning technique for improved prediction of cancer survival probability by using
the gradient boosting method for optimizing the Brier score over a high-dimensional feature
space. The new method offers improved precision of prediction, computational efficiency,
and improved understanding of the contributing features (important biomarkers). We will
illustrate the model via a data set for diffuse large B-cell lymphoma.

1.2

Survival data analysis

In the current data-driven world for cancer studies, survival data can be analyzed by a great
number of methods. However, those methods might be categorized into two major classes,
which are statistical and machine learning methods. Traditionally statistical methods play
a crucial role in survival analysis. Non-parametric methods such as Kaplan-Meier product
limit estimators [3], Nelson-Aalen estimators [4] and life-table [5] laid a strong foundation
for early related research. Nevertheless, non-parametric methods do not offer insights on the
contribution of quantitative covariates to the survival probability. Thus, semi-parametric
approaches such as the Cox’s regression models [6] have been more popular for survival analysis, which allow us to take into account the impacts of covariates based on the proportional
hazards assumption. Some commonly used Cox’s regression models include penalized Cox
regression such as Lasso and Ridge regression [7] [8] and time-dependent Cox models [9].
However, the restriction of Cox models is often due to the violation of proportional hazards
assumption. In fact, the assumption is often not met for many survival data. Therefore,
parametric models such as linear regression (Buckley James) [1], penalized regression [10]
or the accelerated failure time (AFT) models [11] are often used. However, when we have a
high dimensional feature space, the application of these statistical methods could be limited
due to its associated computational complexity. Hence, the machine learning methods which
are more powerful for big data analysis could be a more popular alternative for analyzing
high dimensional survival data. Some well-known machine learning tools that have been
adapted for survival analysis include survival trees [12] [13], Bayesian network [14], neutral

network [15], support vector machine [16], ensemble methods such as random survival forest [17] and bagging survival trees [18], gradient boosting [19] [20] and some more advanced
learning methods such as active learning, transfer learning [21] and multi-task learning [22].

This thesis mainly focuses on gradient boosting methods, which offers both the simplicity
of statistical methods and the computational power of machine learning techniques. Existing
work on applying boosting methods to survival analyses have explored a variety of objective
(loss) functions such as the negative partial log-likelihood [19], the ranked-based Gehan
loss [23], the (smooth) C-index [24]. In this thesis, we are going to propose a new gradient
boosting method using the modified Brier score as the loss function to optimize a aspect
of model performance and demonstrate its advantage over some existing gradient boosting
methods through a simulation study.

1.3 Diffuse Large B-cell Lymphoma (DLBCL) Studies
Diffuse large-B-cell lymphoma is a disease involving molecular heterogeneity. In [25], three
gene expression signatures, which are germinal-center B-cell, stromal-1 and stromal-2, were
used to build a multivariate model. The Affymetrix U113 plus 2.0 microarrays was used to
profile the gene-expression. The data set explored in this thesis includes microarray data of
diffuse large B-cell lymphoma of patients received the gold standard CHOP treatment [25].
Originally, survival time and status of 181 patients were recorded with 54,675 covariates.
However, those covariates are filtered by a pre-selection procedure for high-dimensional data.
Previous study [25] showed that the survival rate post treatment was influenced by differences
in immune cells, fibrosis and angiogenesis. The previous study [25] also had access to a larger
data set, which contains demographic of patients, Ann arbor stage, extra nodal sites, ECOG
performance status and IPI score. Rosenwald et al. [26] indicated that the cure rate of
patients who have extensive disease was around 0.35 to 0.40. It is also showed in [25] that
the relative risk of death was 2.76% with 95% CI (1.9,3.9). Zhu Wang and C.Y.Wang [1]

used the same data set to evaluate the performance of Buckley-James boosting algorithm.
Twelve probe sets were selected in this study which summarized shown in Table 1.1.
Table 1.1: Probe set ID and corresponding gene symbol derived from Zhu Wang and
C.Y.Wang BJ boosting [1]
Probe set
Gene symbol
Coefficient
1558999 x at LOC283922/PDPR
−0.104
−0.098
1561016 x
1562727 at
−0.045
1568732 at
0.116
212713 at
MFAP4
0.058
224043 at
UPB1
0.121
SCARA5
0.112
229839 at
237515 at
TMEM56
−0.019
DNM1L
0.212
237797 at
−0.010
240811 at
242758 x at JMJD1A
0.112
244346 at
0.111

2
2.1

Statistical Methods for Survival Analysis

Survival Data and Functions

In the study of time-to-event data, we may not be able to observe the exact event time
for the units in the study. For instance, in a study about the survival time of a particular
cancer, we are interested in when the death of a patient occurs. However, not all patients
die during the study period, For patients who have survived by the end of the study, the
exact event times are not observed, i.e the ”failure” are expected to occur after the recorded
time period. On the other hand, in retrospective studies, the failures have occurred before
the termination of the study. Two main objectives of survival modeling are to estimate the
survival probability of a patient and to determine which covariates have significant impacts
on the survival probability.

Let (Ti , δi , Zi ) be the survival data for the ith patient, where Ti is the observed event
time, δi is the status death or being alive and Zi is a set of covariates associated with patient
i. The survival function, which is the probability of an object surviving beyond a given time
t, is
S(t) = P (T ≥ t) = 1 − P (T ≤ t) = 1 − FT (t), for t ≥ 0,
where FT (t) is the cumulative distribution function at time t. The hazard function is a
conditional density, given that the event of interest has not happened prior to time t, which
can be expressed as
P (t ≤ T < t + h|T ≥ t)
f (t)
=
.
h→0
h
S(t)

h(t) = lim

The cumulative hazard function is given by
Z

t

h(s)ds = − log S(t)

H(t) =
0

We also have a useful relationship given by
d
d
h(t) = − log[1 − F (t)] = −
dt
dt

2.2




− log S(t) .

Kaplan-Meier Product Limit Estimator

Kaplan-Meier (KM) product limit estimator is a non-parametric statistic used to estimate the
survival function of the time-to-event (lifetime) data [3]. Sometimes, patients in a particular
treatment program may leave the program. This will result in partial observations, i.e it is
known the patient has survived a certain time but the exact failure time is unknown. The
KM estimator of survival function - first introduced by Edward L.Kaplan and Paul Meier,
is given by
Ŝ(t) =

Y 
i:ti ≤t


di
1−
,
ni

where ti is the observed event time, di is the number of events that are recorded at time t
and ni is the number of patients survived by time ti . The KM estimator is one of the most
commonly used statistics in non-parametric survival analysis, due to its ease for computation
and visualization. Nevertheless, it does not allow an connection with qualitative predictors.
Survival data sets with continuous covariates are often treated by parametric survival models
or Cox proportional hazards models. To assess the uncertainty of KM estimates, we use
γ̂i =

di
ni

to calculate binomial proportions of death in the time interval [ti , ti+1 ). The variance

of γi is then given by
V ar(γ̂) =

γ̂i (1 − γ̂i )
.
ni

Then the Greenwoods’s formula yields

ˆ Ŝ(t)) = [Ŝ(t)]2
Var(

di
.
(n
−
d
)n
i
i
i
i:t ≤t
X
i

Even though the non-parametric method is flexible, it is difficult to incorporate the
quantitative covariates. That means it is hard to connect how individuals differ in their
survival probability with other features through the KM estimates. However, the KM curve
can serve as an a useful tool to validate the Cox proportional hazards assumption. If the KM
curves of two groups intersect, it may be an evidence of non-proportional hazards between
the two survival curves.

2.3

Cox Proportional Hazards Models

The proportional hazards model, which is in a family of semi-parametric model, assumes
that the ratio of hazards of groups remain a constant as time changes [6] [27]. Let zi =
(zi1 , ..., zip ), i = 1, ..., n be the set of covariates associated with the ith patient. The hazard
function of Cox proportional hazards model is expressed as

λ(t|zi ) = λ0 (t) exp(η) = λ0 (t) exp(zTi w),

where λ0 (t) is the baseline hazard (when all covariates are zeros), w = {w1 , ..., wp } is a vector
of coefficients and η = zTi w = w1 zi1 + ... + wp zip is the prognostic index. The parameters in
Cox proportional hazards model is estimated via maximizing the partial likelihood, which is
given by:
pl(w) =

n 
Y
i=1

exp(ziT w)
P
T
j∈R(Ti ) exp(zj w)

δi
.

In the above equation, R(Ti ) is the set of patients at risk at time ti , and is defined as
R(ti ) := {j : Tj ≥ ti }. Tsiatis (1981) [28] and Andersen and Gill (1982) [29] proved that it is
possible to use the partial likelihood in place of the full likelihood to make inferences about

w. First, we derive the log-partial likelihood by taking logarithm of the partial likelihood
function, which can be writen as

l(w) = log pl(w) =

n
X

δi zTi w

− log

 X

i=1

exp(zTj w)


(1)

j∈R(Ti )

Let G(w) be the partial likelihood score function, which is given by the first derivative
of the log-partial likelihood as in

G(w) =

∂
l(w).
∂w

The solution of G(w) = 0, denoted by ŵ is the maximum partial likelihood estimate of
w. Tsiatis, et.al [28] also proved that

ŵ−w
SE(ŵ)

asymptotically follows the standard normal

distribution. Additionally, the variance of ŵ can be computed as

Var(ŵ) =

∂2
l(w)
−
∂w2

−1
|w=ŵ .

The proportional assumption can be validated by several methods, such as visualization
through the Kaplan-Meier curves or using the Schoenfeld residual test [30].

2.4

Accelerated Failure Time Models

An accelerated failure time (AFT) model is characterized as an parametric survival model,
which has a completely specified the distribution of survival time [31]. Unlike proportional
hazards models, an accelerated failure time model assumes that the survival time is accelerated or decelerated under the effect of covariates, i.e the model describes the acceleration or
deceleration of the survival time as a function of the covariates, which can be mathematically
presented as
S(t) = S0 (kt), t ≥ 0,

where S and S0 are survival functions of two populations and k is a constant accelerating
factor. Let λ(t) be the hazard function of an AFT model and θ = exp(−ZiT w), then the
accelerated failure time model can be given by:

λ(t|θ) = θλ0 (θt).

Let Ti be the failure time of the ith instance, and then we have
log(Ti ) = − log(θ) + log(θTi ) = ZiT w + σi ,
where w = (w1 , ..., wp )T and σ are the unknown parameters.
The estimation and inference of the AFT models have been introduced by Kalbeisch and
Prentice [32]. Let Yi = min(log Ti , log Ci ), where Ci represents the censoring time of patient
i, which is assumed to be independent of w and σ. Let yi be the observed data of Yi , then
the log-likelihood function is given by






n
X
yi − ziT w
yi − ziT w
l(w, σ) =
δi log f
− log(σ) + (1 − δi ) log S
,
σ
σ
i=1
where f (.) and S(.) are the corresponding density and survival functions of i . Let ei =
yi −ziT w
,
σ

then the score function of the log-likelihood of the AFT models can be written in

the matrix form of

U (w, σ) =

Uw (w, σ)
Uσ (w, σ)




=

σ −1 Z T Γ
σ −1 (eT Γ − 1T δ)

where Γ = (γ1 , ..., γp )T ,


∂ log f (ei )
∂ log S(ei )
γi = − δi
+ (1 − δi )
,
∂ei
∂ei


,

1T = (1, ..., 1)T and e = [exp(e1 ), ..., exp(ep )]T . The maximum likelihood estimates (MLEs)
for w and σ are derived by solving U (w, σ) = 0, which can be obtained by a numerical
nonlinear optimizer, such as the Newton-Raphson algorithm (which is the optimization algorithm used in the ”survreg” function in the R survival package).

One of the most commonly used AFT models is the log-logistic model, which has a nonmonotonic hazard function. The hazard function of the log-logistic model increases at the
early lifetime, and then decreases later on. The distribution of the errors of the log-logistic
model is given by
γi = δi ei

1 − δi ∂
Φ(ei ),
1 − Φ(ei ) ∂ei

where Φ(.) is the cumulative density function of the standard normal distribution. In contrast, the Weibull distribution has a PDF given by
 α−1
α t
f (t) =
exp(−(t/β))α ,
β β
where α and β are the shape and scale parameters, respectively. The Weibull distribution
has a monotonic hazard function, whose shape is dependent on the shape parameter. Particularly, the shape parameter less than one indicates a monotonically decreasing hazard
function. In the case of a unit shape parameter, the Weibull distribution is simply an exponential distribution with a constant failure rate. The error distribution follows a standard
extreme value distribution, which is given by

γi = exp(ei ) − δi .

The uncertainty of the estimated parameters (wT , σ) can be performed by hypothesis testing [32]. Let Θ = (w, σ T ) be the parameter space, which can be partitioned into Θ =
(2)

{θ(1) , θ(2) } = {(w1 , σ1 ), (w2 , σ2 )}. Let Θ0 = {(θ(1) , θ0 )}, then the hypothesis test on H0 :

(2)

θ(2) = θ0 is performed by the likelihood ratio test


(1)

(2)

Λ = 2 l(θ̂ , θ̂ ) − l(θ

(1)



(2)
, θ0 )

.

It is previously proved that Λ has a χ2 distribution with its degree of freedom equals the
length of θ(2) .

3

3.1

Machine Learning Methods

General Boosting Methods

In this section, we are going to introduce the fundamental of the boosting methods, starting
from the forward stagewise boosting, continuing on with the additive tree-based boosting,
and then proceeding with the gradient boosting, which has been the most popular boosting
methods and have demonstrate their successes through many applications and being among
the winner solutions of many Kaggle competitions. The main idea is to build an ensemble of
weak learners by optimizing a loss function of interest via a steepest decent algorithm. To
scale for a high-dimenational feature space, the component-wise gradient boosting methods
with various choices of the loss function will be explored.

3.2

Forward Stagewise Boosting

Boosting has become one of the most efficient and well-performed learning structures, which
has been continuously developing in the last two decades. The first simple form of the boosting procedure was proposed by Schapire (1990) [33], and had drawn an extensive attentions of
many researchers. Originally, the algorithm was created for classification problems; however,
it was later on adapted to handle regression problems as well. One of the well-known developments is Adaptive Boosting (AdaBoost) for classification problem formulated by Yoav
Freund and Robert Schapire. [34] Then Friedman et al. [35] introduced the additive tree models, which are applicable for both regression and classification problems. The idea behind
boosting is to ensemble weak learners, which are slightly better than random guessing, into

a more powerful model for improved predictions. Forward stagewise additive modeling [36]
could result in an easy interpretation (Algorithm 1). Mathematically, the model is given by

f (z) =

M
X

wm b(z; θm ),

(2)

m=1

where wm , m = 1, ..., M are the coefficients (weights) and b(z; θm ) are real functions of z,
characterized by a set of parameters θm . We also need to define the loss (objective) function,
denoted by Φ(y, f (z, θ)). The loss function must be a convex function. There are many
choices of the loss function such as the squared-error loss, the absolute-error loss, Huber
loss, etc. [36] In survival analysis, the negative partial log-likelihood function can also be
used as the loss function [37].

Beginning with a chosen initial value of f0 (z), typically chosen as zero, forward stagewise
modeling adds a new basis function at each iteration, keeping the same set of parameters
and coefficients that have been already included in the model. The aim of the mth iteration
is to find the ”best” base leaner and its weights b(z, θm ) and wm which minimizes the loss
function Φ(y, fm (z)). This result, says wm b(z; θm ) is added to the result derived from the
(m − 1)th iteration to form a new model. The parameter estimation is relying on the choice
of base leaners and the loss function. For example, in the case of the simple linear regression
(SLR) base learners and the squared-error loss function, we have

Φ(y, fm (z)) =

n 
X
i=1

yi −

M
X
m=1

2 X
2
n 
M
X
wm b(z; θm ) =
yi −
wm θm Z
i=1

m=1

The estimates for θ̂m and ŵm are solutions to the system of equations
n
X
i=1

∂
Φ(yi , f (z)) = 0
∂wm

and
n
X
∂
Φ(yi , f (z)) = 0,
∂θ
m
i=1

which can be obtained by numerical methods. Nevertheless, in the next section, we will introduce the boosting trees, which use the tree-based base learners. The parameter estimation
process is more complicated than the above example.
Algorithm 1 Forward stage-wise boosting Additive Model
1. Initialize f0 (z) = 0
2. For m = 1 to M :
(a) Compute


N
X
(ŵm , θ̂m ) = arg min
Φ y, fm−1 (zi ) + wm b(zi ; θm ) .
wm ,θm

i=1

(b) Update fm (z) = fm−1 (z) + ŵm b(z; θ̂m )

3.2.1

Boosting Trees

In addition to the forward stagewise additive modeling, boosting tree is another powerful
boosting method. Classification and regression trees (CARTs) partition the feature space
into disjoint regions Rj , i = 1, ..., J [36]. Each of the regions, defined by their terminal nodes
will be assigned a constant Cj , then the prediction is obtained by: z ∈ Rj =⇒ f (z) = Cj .
Generally, the mathematical form of a tree is

T (z; Θ) =

J
X

Cj I(z ∈ Rj ),

j=1

where Θ = {Rj , Cj }Jj=1 are the parameters associated with the J prediction regions. The
estimation of the model parameters is basically a optimization problem, which is to minimize
P P
the empirical risk Jj=1 zj ∈Rj Φ(yi , Cj ). The solution can be obtained using the greedy or

top-down recursive partitioning strategy for finding Rj such that

Θ̂ = arg min
Θ

N
X

Φ̂(yi , T (z; Θ)).

i=1

The boosting tree model also has an forward stagewise expression, as it can be represented
by
fM (z) =

M
X

T (z; Θm ).

m=1

The implementation of boosting trees with the gradient boosting in XGBoost package has
achieved tremendously outstanding result among current data analysis competitions. [38]
Algorithm 2 Steepest Descent Algorithm
1. Initialize f0 = 0
2. For m = 1 to M :
(a) Compute the negative gradient vector u[m]


δΦ(yi , f (zi ))
[m]
ui = −
δf (zi )
f (zi )=fm−1 (zi )
(b) Compute the step length νm
νm = arg min Φ(fm−1 + νu[m] )
ν

(c) Update
fm = fm−1 + νm u[m]

The main task of algorithms introduced above is to find a set of parameters which minimizes the loss function. The optimization problem can be solved numerically by the gradient
descent algorithm (analytically called method of steepest descent) [36]. We can restate the
PN
optimization as the following. Let Φ(f ) =
i=1 Φ(yi , f (zi )) be a convex and differential
loss function. We need to find f = {f (z1 ), ..., f (zN )} which minimizes Φ(f ), mathematically

denoted by
fˆ = arg min Φ(f )
f

The solution given by the steepest descent algorithm is expressed as

fM =

M
X

νm u[m] ,

m=0

where νm u[m] is the increment vector at the mth step. The steepest descent is a greedy
algorithm, since the negative gradient vector u[m] is the local direction where the loss function
decreases most quickly.
Algorithm 2 can be adapted into boosted tree modeling, to handle the difficulty of finding
Rj .
Algorithm 3 Gradient Tree Boosting Algorithm
1. Initialize
f0 (y) = arg min

N
X

θ

Φ(y, θ).

i=1

2. For m = 1 to M :
(a) For i = 1, ..., N compute the pseudo residuals


δΦ(yi , f (zi ))
rim = −
.
δf (zi )
f =fm−1
(b) Fit a regression tree to predict rim , obtaining terminal regions Rjm , j = 1, ..., Jm
(c) For j = 1, ..., Jm compute
θjm = arg min
θ

X

Φ(y, fm−1 (z) + θ)

zi ∈Rjm

(d) Update
fm (z) = fm−1 (z) +

Jm
X
j=1

3. Output fˆ(z) = fM (z)

θjm I(z ∈ Rjm ).

3.3

Gradient Boosting Based on Optimizing the Partial Likelihood

Although the gradient boosting algorithm has a great number of advantages, there exists a
concerning issue, which is variable selection. In contemporary data-driven world, we usually
deal with high-dimensional data, which demands computationally expensive analysis, as
well as appropriate methods for variable selection. Especially, microarray data used in
biomedical research has an enormous number of predictors, much greater than the number
of observations. Therefore, Cox’s proportional hazard model is not practical to be used.
Component-wise boosting for multivariate linear model proposed by Peter Buhlmann et.al
(2006) is a remedy for the issue [37] [39]. Instead of fitting the base-learners for the entire set
of covariates Z = {z1 , ..., zp }, component-wise boosting uses base-learners to fit one variable
at a time zj , j = 1, ..., p, and then select the best update in each iteration see (Algorithm 4).
The negative log-partial likelihood is chosen to be the loss function

Φ(δi , f (z, w)) = −l(w) = − log pl(w) = −

n
X
i=1

δi zTi w

+ log

 X

exp(zjT w)


.

j∈R(Ti )

The final model has the same form as the regular Cox’s regression model, however the set of
weights w is obtained by Algorithm 4.

3.4

Gradient Boosting via Optimizing the Concordance Index (C- index)

The concordance index (C-index) or Harrell’s CH is one of tools used for evaluating the
performance of a survival model. Given a pair of patients (i, j) with prognostic indices (ηi , ηj )
and the corresponding survival times (Ti , Tj ). The C-index is defined as the probability of
a patient having larger prognostic index but actually survives in shorter period of time.

Algorithm 4 Component-wise Gradient Boosting
1. Initialize ŵ[0] = (0, ..., 0) and the learning rate 0 ≤ ν ≤ 1.
2. For m = 1 to M , compute:
u[m] =

∂Φ(y, f (z, w))
∂f (z, w)

=−
w=ŵ[m−1]

∂l(w)
∂w

w=ŵ[m−1]

3. For zj in Z = {z1 , ..., zp }:
(a) Fit base-learners b(zj , θj ) with response variable u[m] and obtain the least squared
estimator θˆj .
(b) Select an index k in {1, ..., p}, such that:
n
X
k = arg min
(u[m] − zTj θ̂j )2
j

i=1

4. Update w[m] = w[m−1] + ν θ̂k

Particularly, C-index is given by

C = P (ηi > ηj |Ti < Tj ).

Andreas Mayr et al. [40] used the smoothed C-index as the loss function of componentwise gradient boosting algorithm. Due to the natural discrete form of C-index, the authors
proposed a smoothed version of this statistic, which is given by approximating the indicator
function I(ηj > ηi ) by sigmoid function.

sig(ηj − ηi ) =

1
η −η .
1 + exp(− j σ i )

It is also assumed that the survival probability is estimated non-parametrically by a KaplanMeier curve K(.). The smoothed C-index is a continuous function of time T and prognostic

index η, which has mathematical form
P
Ĉsmt (t, η) =

δj
i,j K(tj )2 I(tj < ti )sig(ηj
P
δj
i,j K(tj )2 I(tj < ti )

− ηi )

(3)

In the same study, the authors achieved a model with the best discriminatory C-index by
altering the loss function l(w) in Algorithm 4 by the negative of equation 3 . However,
we will later show that in the trade-off of the choice of loss function, the Brier’s score of
(smooth) C-index is outperformed by gradient boosting Brier’s score.

3.5

Gradient Boosting via Optimization of the Gehan Loss

Algorithm 5 Component-wise Gradient Boosting using rank-based Gehan loss.
1. Initialize ŵ[0] = (0, ..., 0) and the learning rate 0 ≤ ν ≤ 1.
2. For m = 1 to M , compute:
u

[m]


n 
n


∂ 1X 1 X
δi
=−
ri (w) − rj (w) I ri (w) ≤ rj (w)
∂w n i=1 n j=1

w=ŵ[m−1]

3. For zj in Z = {z1 , ..., zp }:
(a) Fit base-learners b(zj , θj ) with response variable u[m] and obtain the least squared
estimator θˆj .
(b) Select an index k in {1, ..., p}, such that:
k = arg min
j

n
X

(u[m] − zTj θ̂j )2

i=1

4. Update w[m] = w[m−1] + ν θ̂k

The proportional hazards assumption is vital for above algorithms, since the final models
will be Cox regression model. However this assumption is often neglected, thus AFT model
can be a promising alternatives for Cox proportional hazard model. There are a well-known
method proposed to approach boosting AFT model, namely Hothorn et al. (2006) using the

inverse-probability weighting (IPW). Nevertheless, Johnson and Q.Long et al. (2011) [23]
proposed tree-boosting rank-based Gehan loss for semi-accelerated failure time model, which
defines as the weighted sum of pairwise differences. Let Oi be the fully observed failure time,
we have

n
n 


1 X
1X
ri (w) − rj (w) I ri (w) ≤ rj (w) ,
− δi
Φ(δ, w) = −
n i=1
n j=1
where ri (w) = log Oi − wT zi .
We employed the Gehan rank-based gradient boosting in our research, due to several
reasons, which will be address in chapter 4.

4 Gradient Boosting via Optimization of Modified
Brier Score

The Brier score is developed to evaluate the accuracy of probabilistic predictions in
survival analysis. The response of survival analysis is often binary (death or alive). The Brier
score measured the squared discrepancy between the response and the predicted survival
probability. A better model should have a lower Brier score. Therefore the objective of each
boosting step is to minimize the modified Brier score, which is defined as

B(w) = Φ(δi , f (zi , w)) =

n
X
i=1

2

(δi − S(t|z)) =

n 
X

exp(zT
i w)

δi − S0 (t)

2
.

(4)

i=1

The modified version neglects the constant term 1/n in the original version, which will not
affect the optimization. The gradient vector of the ith instance is given by

ui =

∂B(w)
∂Φ(δi , f (zi , w))
=
.
∂f (zi , w)
∂w

By taking partial derivatives of the components wj , j = 1, ..., p of the coefficient vector w,
we have


∂B(w)
T
T
exp(zT
w)
i
uij =
= −2zij log(S0 ) δi − S0 (t)
exp (zTi w)S0 (t)exp(zi w) .
∂wi
Unlike the above algorithms, here the target of boosting is not the prognostic index, but
instead being the survival probability. Thus, the form of first order derivative is more

Algorithm 6 Component-wise Gradient Boosting using Brier’s score as the loss function
1. Initialize w[0] = (0, ..., 0) and learning rate 0 ≤ ν ≤ 1.
2. For m = 1 to M
(a) Compute the gradient vector:
∂Φ(δi , f (zi , w))
∂f (zi , w)


T
T
exp(zT
w)
i
exp (zTi w)S0 (t)exp (zi w) .
= −2zij log(S0 ) δi − S0 (t)
uij =

w=w[m−1]

(b) Compute all possible updates of weight vector w[m] using least square method:
θ̂j = (zTj zj )−1 zTj uj
(c) Find the best update k, which is
k = arg min
j

n
X

(ui − zTj θ̂j )2

i=1

(d) Update
[m]

[m−1]

wk = wk

+ ν θˆk

3. Output: Weight vector w[M ]

complicated. The variable selection is performed via the component-wise approach. For
the ith observation, we obtain a gradient vector uij of length p. Thus, at each iteration, a
gradient matrix of dimension n × p is produced, which can be written as :




 z11 ... z1p 


 z21 ... z2p 










zn1 ... znp

n×p





w11 ... w1p 


w21 ... w2p 










wp1 ... wpp

p×p





 u11 ... u1p 


 u21 ... u2p 


=







un1 ... unp

n×p

Let zi , wi and ui be column vectors of length n in above matrix. We can rewrite the matrices

above as partition matrices in the form of



z1 | ... |zp







w1 | ... |wp = u1 | ... |up

The component-wise routine is used to fit the base learner on response ui and predictor zi ,
reproducing all possible updates on the set of weights.
In the later section, it is found that the algorithm outperforms its competitors in terns
of minimizing the Brier score, both in training and testing cohorts.

5

5.1

Parametric Analysis for the DLBCL data

Kaplan-Meier Estimate of the Survival Function

The Kaplan-Meier curves provides us a general view on the data set. Within first 5 years,
the baseline survival probability drops significantly to 46.7%. In the next 5 years, the rate
is continuing drop but gradually instead, to 34.6% by 10.6 years. Patients, who have been
survived beyond year 11th possess a survival chance of 31.8%. A first glance at the histogram
of survival time (in year) (Figure 5.1), we proposed that an exponential distribution would
be the best fit for the baseline survival distribution. However, the analysis thereafter will
include exponential distribution, as well as the Weibull 2 parameters, log-normal and loglogistic. We found that the log-logistics model is the best-fitted distribution the baseline
survival time. (Table 5.1)

5.2

Parametric Estimate of the Survival Function

Table 5.1: Results of parametric models on DLBCL survival time with comparing metric of
AIC information criteria.
Exponential
Number of parameters
1
AIC
624.97

Weibull Log-normal Log-logistics
2
2
2
571.77
582.54
566.54

The probability density function of Log-logistics distribution (Fisk distribution) is given

by:
f (t; α, β) =

(β/α)(t/α)β−1
,t ≥ 0
(1 + (t/α)β )2

The scale parameter α is a positive number and also median value of the distribution. On
the other hand, shape parameter β < 1 indicates that there does not exit unimodality in the
model. As a consequence, the expected life time is undefined. The cumulative distribution
function is
F (t; α, β) =

1
1 + (t/α)−β

Figure 5.1: Kaplan-Meier product-limit estimate of survival time with 95% confident interval
(shaded region)

By using maximum likelihood estimation and Newton-Raphson algorithm [41] implemented in R-studio, MLEs of scale and shape parameters are α̂ = 4.071465 and β̂ = 0.715382,
respectively.

Figure 5.2: Histogram and probability density function (PDF) of log-logistic fit on the
survival time.
As a result, the density distribution of survival time has the form

f (t) =

0.1757(t/4.07165)0.284618
, t > 0.
(1 + (t/4.071465)0.715382 )2

Figure 5.3 illustrates that the assumed density curve has long fat tail and positive skewness.
The majority of area under the curve (71.77%) is within 10 years, i.e P (T ≤ 10) = 0.7177.
The medical interest is often to estimate the survival rate of a patient with first 5 years,
which is
P {A patient survives up to 5 years} = P (T ≤ 5) = 0.5367.
Noticeably, the survival rate between year 5th to year 10th drops to under 11.8718%, given
that this patient has survived beyond year 5. Thus, we can classify patients surviving in this
period as high risk group, in contrast to who are still alive up to 5 years (Figure 5.3).

Figure 5.3: Corresponding cumulative distribution function (CDF) of log-logistic fit on the
survival time

5.3 Boosted Tree Classification Model
In the next part of this chapter, we will validate the proportional hazards assumption. Using tests and plots from the scaled Schoenfeld residuals. The violation of the proportional
hazard assumption is represented by a non-zero slope. Therefore, any nonlinear relationship,
which is discovered in the plot of the residuals as a function of time, can indicate the violation of proportional hazard assumption. Additionally, in case of high dimensional feature
space, [42] proposed that covariates with most importance score (best separate alive and
deceased patients) can be used to validate the assumption. Firstly, we create a tree-based
classifier which implement the Extreme Gradient Boost (XGBoost) [38] with the binary logistic function as the loss function. To perform the classifying process, we create a grid
search for hyper-parameters, which include the learning rate ν and maximum depth of a tree
T.
It is shown that the stopping criteria is highly related to the learning rate, thus we

Table 5.2: First 20 covariates from the Cox’s proportional hazard test, with Chi-square
statistic and p-value.
X217320 at
X242936 at
X1553607 at
X238498 at
X1561316 at
X233046 at
X238845 at
X1555939 at
X229839 at
X1568574 x at
X1560025 at
X232947 at
X241235 at
X224221 s at
X1568751 at
X1562309 s at
X244546 at
X210600 s at
X1561140 at
X231478 at
GLOBAL

ρ
0.03408516
−0.04952279
−0.14325457
0.06975792
−0.19253580
0.01307213
0.05242758
−0.02398130
0.06160926
−0.11670569
0.12852035
−0.22203410
−0.17320187
−0.09565856
−0.04222970
−0.01698123
−0.06535564
−0.07831158
−0.10121657
−0.02512684

χ2
0.61760805
1.52970279
10.14971603
1.51952073
18.86935049
0.05749129
2.03359225
0.34493307
2.06830635
4.24673681
8.58176531
28.38298975
20.68739285
6.28885046
1.48853993
0.13654472
2.13214249
3.69695166
4.06587337
0.21626282
180.64060816

p-value
0.43193754
0.21615706
0.00144323
0.21769203
0.00001400
0.81050593
0.15385658
0.55699551
0.15038845
0.03932583
0.00339546
0.00000010
0.00000541
0.01214998
0.22244314
0.71174048
0.14423902
0.05451197
0.04375805
0.64190234
0.00000142

can choose an arbitrary value of learning rate between 0 and 1. The algorithm separates
two classes remarkably well, reaching 82.32% of accuracy in leave-one-out study. At each
fold, an importance matrix is obtained by measuring the frequency of chosen features. One
thing worth mentioning is that the feature selection is stable, which means the algorithm
deriving the same importance matrix at each fold. In (Figure 5.4), the bottom panel shows
the importance of a covariates based on its selected frequency, whereas the top panel in
the relative importance defined by the fraction of frequency of a covariate over the most
importance covariate (X 217320 at). Secondly, we fit the Cox’s regression model on the top
100 covariates to assess graphical results from Schoenfeld residuals as a function time, as
well as the goodness-of-fit test. Table 5.2 shows first 10 results (out of 100) of the goodnessof-fit test on proportional assumption. As we can see, there actually are several probe sets

Figure 5.4: Importance ranked by the frequency of to be chosen by XGboost algorithm,
ordered from top to bottom.

Figure 5.5: Schoenfeld Residuals Test Results: The solid lines smooth the spread of Schoenfeld residuals in neighborhood of 0.
satisfying the proportional hazard assumption, such as X217320 at, X242936 at, X238498 at,
Et cetera.

However, the global test indicates the violation of proportional hazard assumption, χ2 =
180.64 at significance of 0.00000142. Furthermore, the plots of Schoenfeld residuals as a
function time again indicate non-proportionality, where non-linear relationship appears in
plots of X1553697 at and X1561316 at.

6

Simulation Study

A simulated study was conducted in order to evaluate and compare boosting methods. For
simplicity, the simulated data (n = 1000) is assumed to be exponentially distributed, due to
the constant hazard. We also set the ground truth, which contains the first five active covariates with coefficients of 0.5({βi }5i=1 = 0.5) and the remaining 995 is non-active covariates.
The baseline PDF of survival time (Figure 6.1) is generated from

f (t) = 0.5e−0.5t

and



λ(t|Zi )
log
= 0.5 × z1 + 0.5 × z2 + 0.5 × z3 + 0.5 × z4 + 0.5 × z5
λ0 (t)

First of all, we repeat the parametric analysis to obtain the baseline distribution of
survival time. The estimated distribution of baseline survival probability is

Sˆ0 (t) = e−0.508517t

Since the data is simulated, we are certain that the proportional hazard is satisfied. One
of the most versatile methods for survival analysis is Lasso Cox regression (L-Cox). Based
on L1 -norm penalty, L-Cox shrinks the coefficients of non-significant covariates exactly equal
to zero, performing feature selection by finding minimum penalty. We performed 5-fold cross

Figure 6.1: Baseline survival probability density function of simulated data, using exponential survival function.

Figure 6.2: 5-fold cross-validation of L-Cox model, using partial likelihood deviance as scoring
criteria for parameter tuning (log(λ))

Table 6.1: Comparison of gradient boosting algorithms in large simulated data (p = 1000).
L-Cox
gbL
gbC
gbG
gbB
Number of selected features 10(5) 10(5) 11(5)
5(5) 12(5)
Train Brier’s score
0.5322 0.5642 0.6723 0.9063 0.2763
Test Brier’s score
0.9458 1.2834 1.3385 1.5032 0.5398
Test C-index
0.7112 0.6908 0.8977 0.6811 0.6673
validation on the simulated data, in order to obtain the best penalty λ, which minimizes the
partial likelihood deviance. Figure 6.2 shows that λ = 0.06479103 gives us the best L-Cox
model with 10 selected covariates. 5 out of 10 selected covariates are correct and relatively
closed to the ground truth.
Table 6.2: Comparison of gradient boosting algorithms in smaller simulated data (p = 10).
L-Cox
gbL
gbC
gbG
gbB
Train Brier’s score 1.2036 1.4108 1.7166 1.9862 0.5589
Test Brier’s score 2.0143 2.4234 2.6523 2.9087 0.9887
Test C-index
0.6267 0.5802 0.7419 0.5792 0.5017
Table 6.3: Estimate of coefficients from simulated data with optimally tuned parameter by
implementation of grid search.
β1
gbL
0.405619
gbG
0.457558
L-Cox 0.460840
gbB
0.487321
gbC
0.384246

β2
0.197475
0.195512
0.252616
0.398092
0.492172

β3
0.150577
0.115215
0.208977
0.467893
0.501973

β4
0.479283
0.562434
0.529942
0.367896
0.439576

β5
0.501966
0.547816
0.553262
0.401365
0.497782

We suspect that the number of non-active covariates (p = 995) is the reason for the overfitted number of covariates. Thus, we created a smaller data set with only 10 covariates. The
ground truth is remained the same as the first simulated data. We now apply four gradient
boosting algorithms on the simulated data, which are gradient boosting via optimization of
partial log-likelihood (gbL), modified Brier score (gbB), smoothed C-index and Gehan loss
function (gbG). As a result, all of the algorithms select the correct set of active covariates.
In Table 6.1, gbC produced the best C-index, while the remaining algorithms have a slightly
smaller C-index. However, the Brier’s score of gbC is significant higher than gbB algorithm,

which is only 0.2763 and 0.5398 in train and test set, respectively. On the other hand, gbG
selected the exact number of active covariates, while the other algorithms seem to be overfitted. Table 6.2 is the results of applying these gradent boosting on the smaller data set.
Again, the gbC has the largest C-index of 0.7419, significant higher than other. Nevertheless,
gbB outperforms other algorithms with aspect of minimizing the Brier’s score, achieving the
smallest Brier’s score of 0.5017 in test set and 0.9887 in train set.

7

Gradient Boosting for Analyzing the DLBCL data

We compare four methods based on the component-wise gradient boosting algorithms,
which include the gradient boosting via optimization of the partial log-likelihood (gbL), the
modified Brier score (gbB), the smoothed C-index and the Gehan loss function (gbG). To
avoid overfitting, we performed 5-fold cross-validation with a log-logistic baseline, to obtain
the average training and testing errors for both the Brier score and the concordance C-index.
(Table 7.1).
First of all, a gbB model is built on entire data set, to select 211 most important covariates, then the model with selected covariates is used to perform the cross validation. Based
of the modified Brier’s score loss, the gbB outperforms the remaining algorithm, with the
smallest test error of 0.2861, in compare to 0.5230 and 0.9726 of gbL and gbG, respectively.
On the other hand, the log-likelihood of gbB is higher than those of gbL and gbG. Additionally, the C-index of the gbB is 0.7402, which is remarkably smaller than C-indices of the
gbL and gbG (0.92) approaches. The stability of feature selection of gbG is outstanding,
since the algorithm picks up the same number of probe sets (204) after 1000 iterations and
the in-bag log-likelihood converges at approximately 11.648. On the other hand, gbL does
not seem to be converging on the log-likelihood, which has resulted in a continuous increase
in number of parameters as the number of boosting steps increases (*). Thus, we decided to
use only results produced by gbB, gbC and gbG for further analysis.

The two algorithms select a set of 20 common covariates, which includes four probe sets

Table 7.1: Comparison of gradient boosting algorithms with Brier’s score as train-test cross
validation.
Number of selected features
Train Brier’s score
Test Brier’s score
Test C-index

gbL
gbB
gbG
gbC
176-295*
211
204
220
0.5230 0.0933 0.5379 0.6011
0.8466 0.2861 0.9726 0.8473
0.9106 0.7402 0.9173 0.9711

identified by the twin boosting from [1].
The probe sets selected seem to be matching with medical facts after consulting with
subject matter experts. First of all, we would like to briefly interpret the biological relevance of some common probe sets selected by the two algorithms. The most remarkable
probe set found is 239672 at, which possesses gene symbol BLID. A BH3-like motif, which
is encoded by this gene, contains protein associated to cell death. Localizing in both the
mitochondrion and cytoplasm, the protein may be reasonable for apoptosis. The cell death
inducer BH3-like Motif Containing and breast cancer cell protein are aliases for BLID. Besides, HS6ST2 (1552766 at) is heparan sulfate proteoglycans, which plays an important role
in cell growth and migration. Likewise, ADRA1A (237390 at), alpha-1-adrenergic receptors,
create mitogenic responses and regulate growth, as well as induce cell’s proliferation. The
gene may bleed prostatic hypertrophy, which strongly related to prostate cancer. As we
know, cancers are diseases related to abnormal growth of cells. Hence, it is not surprising
our results indicate the two above genes might impact survival probability of a patient. Additionally, probe set 155899 x at, which has gene symbol LOC283922/PDPR, is represented
as Pyruvate Dehydrogenase Phosphatase Regulatory Subunit Pseudogene. This probe set
was also found in [1] with negative coefficient. SLC17A1 gene (1560884 at) is also a protein
coding gene, which might be a reason for gout and hyperuricemia. Its pathways are transportation of glucose and other compounds like sugars, salts, metal ions and acids. 237797 at
is DNM1L gene, which encodes an element of the dynamin superfamily (or known as protein
coding gene). In case of dysfunction, several neurological disorders might be induced, such
as Alzheimer’s disorder. Some diseases related to DNLM1L are encephalopathy induced by

mitochondrial defection and peroxisomal fission 1. The pathways of DNLM1L include CDKmediated phosphorylation and removal Cdc6, the same as ABCA13 (1553605 a at), which is
also discovered by gbB and gbG. Schizophrenia is also mental disease, induced by ABCA13.

Figure 7.1: Plot of deviance residuals with smoothed line indicating the spread around zero
(shaded region is 95% confident interval.)
We now conduct model diagnostics on the gbB model, which includes 220 probe sets.
First of all, we validate the proportional hazards assumption by using the Schoenfeld residuals
test. The test result in a test statistic χ2 = 7.41 with a global significance level of 0.0065,
which is not highly practically significant based on our experience. Thus, there seems no
strong evidence of non-proportional hazards. Second, as we discussed in the previous section,
the gbB algorithm is expected to outperfom other algorithms when the Brier score is selected
as the comparison criterion. Particularly, the gbB model achieves a Brier’s score of 0.03524,
which is remarkably small among existing competitors. In addition, the C-index from the
gbB model is 0.745, which is also considerably smaller than the C-indices of the gbL and
gbG models. In addition, the plot of deviance residuals as shown in Figure 7.1 is generally

Figure 7.2: Importance plot of top 50 probe sets. Top panel: gbB algorithm, bottom panel:
gbG algorithm.
symmetric around the horizontal line at x = 0. In addition, 7 out of 180 might be considered
as influential observations, since the absolute values of deviance excess 2.

Figure 7.3: Top panel: Brier’s score of patients at risk. Bottom panel: Predicted survival
probability of patients at risk.
The importance matrices of the covariates from the gbG and gbB methods are evaluated
based on the frequency that a covariate is selected by the algorithms. As we can see, the
probe set X 229839 at is the dominant key variable in the importance matrix of the gbG

algorithm. While in the gbB importance matrix, the dominant probe sets are X 1570180 at
and X 237390 at. What is worthy mentioning is that probe set X 1558999 x at, which appeared [1] in the top ten important covariates from both algorithms.

Figure 7.3 illustrates the survival probability of patients at risk and time (in months)
and the corresponding Brier score. The first impression from the plot is that the survival
probability within the first 5 years is very high, above 0.8736. After that it gradually
decreases, which matches the inherent nature of the survival probability. Including the
covariates was helpful for improving the prediction of survival experience. On the other
hand, the Brier scores of cases with the occurrence of events observed in the first 5 years
are relatively small (below 0.03), indicating there is higher prediction efficiency for earlier
failures. However, there are still a few observations (such as patients 35, 52, 57, 75, 83, 113
and 152) with relatively large Brier score, which indicates some important probe sets might
still be missing from the fitted model for predicting the survival experience of these group
patients.
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Concluding Remarks

This thesis has applied a number of component-wise gradient boosting algorithms for
analyzing the DLBCL data. In addition, it has developed a new gradient boosting algorithm
based on optimizing the Brier score, and demonstrate the new method outperforms many
existing boosting algorithms on multiple reliability metrics through a simulation study. Although the gradient boosting algorithms are built upon statistical models, they outperform
the traditional statistical methods when exploring high dimensional feature space by leveraging the computing power of the machine learning algorithms. The new gradient boosting
method is demonstrated to minimize the predictive Brier score and the C-Index, as well as
selects the correct features from the simulation study. In addition, the new boosting algorithm also selected a set of covariates from the DLBCL data, which matches with medical
or biological facts and offers insights on a deeper understanding of diffuse large B-cell lymphoma.

The implementation of gradient boosting based on optimizing the Brier score with the
XGboost algorithm has a great potential to further improve the computational efficiency
and accuracy, as the XGboost is much more powerful boosting algorithm than the gradient
boosting. By taking into account the Hessian matrix of the loss function, the future study on
applying XGboosting for optimizing the Brier score can be both challenging and also highly
promising. Another objective of the future study is to create a R package for implementing
the gradient boosting and the XGboosting with the Brier score, which can facilitate broad

applications of the new methods in survival analysis of cancer and other medical data.
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